https://charts.traderzeitung.de/phases/US09060U6064 string(1425) "{"isin":"US09060U6064","name":"BioCardia Inc","stock_id_xnas":65845022,"stock_id_xnys":null,"generated_at":"2026-09-24 01:32:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.08,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":1.02,"close_at":"2026-09-22 01:32:00","complete":true,"perf_pct":-5.5556}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":1.035,"close_at":"2026-09-22 15:29:00","complete":true,"perf_pct":1.4706},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.055,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":1.9324},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":1.055,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":0},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

BioCardia Aktie News & Nachrichten

[WKN: A40D1S | Symbol: BCDA]

Realtimekurs

BioCardia, Inc. is a clinical-stage biotherapeutic company. It engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über BioCardia gefunden werden.

BioCardia Nachrichtenticker öffnen

MT Newswires 05.06.2026 21:50 Uhr

BioCardia sagt, US-FDA bestätigt, dass Herzinsuffizienz-Studie Zulassung vor Markteinführung für CardiAMP System unterstützen könnte

08:41 AM EDT, 06/05/2026 (MT Newswires) -- BioCardia (BCDA) hat von der US Food and Drug Administration die Bestätigung erhalten, dass ihre laufende H

BioCardia Aktie News & Nachrichten

Artikel aus der Redaktion der Trader-Zeitung

Sektor-Update: Gesundheitsaktien am späten Nachmittag höher

Sektor-Update: Gesundheitsaktien legen Freitagnachmittag zu

Top-Mittagsgewinner

Sektor-Update: Gesundheitsaktien steigen vorbörslich am Freitag

BioCardia sagt, US-FDA bestätigt, dass Herzinsuffizienz-Studie Zulassung vor Markteinführung für CardiAMP System unterstützen könnte